Investigational New DrugsSCIE

文章摘录

• The influence of verapamil on the pharmacokinetics of the pan-HER tyrosine kinase inhibitor neratinib in rats: the role of P-glycoprotein-mediated efflux Author: Qi, Defei; Dou, Yuanyuan; Zhang, Wenke; Wang, Mengqing; Li, Yingying; Zhang, Mingzhu; Qin, Jia; Cao, Jinlan; Fang, Dong; Ma, Jing; Yang, Wei; Xie, Songqiang; Sun, Hua Journal: INVESTIGATIONAL NEW DRUGS. 2023; Vol. 41, Issue 1, pp. 13-24. DOI: 10.1007/s10637-022-01314-7
• Icotinib, an EGFR tyrosine kinase inhibitor, as adjuvant therapy for patients with stage IIA-IIIA EGFR-mutant non-small-cell lung adenocarcinoma: a multicenter, open-label, single-arm, phase II study (ICAPE) Author: Qian, Kun; Chen, Qi-Rui; He, Ming; Wang, Zi-Tong; Liu, Yu; Liang, Hua-Gang; Su, Zhi-Yong; Cui, Yu-Shang; Liu, Li-Jun; Zhang, Yi Journal: INVESTIGATIONAL NEW DRUGS. 2023; Vol. 41, Issue 1, pp. 44-52. DOI: 10.1007/s10637-022-01316-5
• Pharmacokinetics and bioequivalence of two pomalidomide capsules in healthy chinese subjects under fasting and fed conditions Author: Liu, Zhengzhi; Xu, Zhongnan; Gao, Zhenyue; Ren, Qing; Chang, Tianying; Xue, Jinling; Yang, Haimiao Journal: INVESTIGATIONAL NEW DRUGS. 2023; Vol. 41, Issue 1, pp. 60-69. DOI: 10.1007/s10637-022-01320-9
• Neoadjuvant toripalimab plus platinum-paclitaxel chemotherapy in stage II-III non-small cell lung cancer: a single-center, single-arm, phase I study in China Author: Hou, Helei; Wang, Yongjie; Sun, Dantong; Zhu, Jingjuan; Jiang, Man; Zhang, Xuchen; Zhou, Na; Zhang, Chuantao; Li, Tianjun; Zhang, Xiaochun Journal: INVESTIGATIONAL NEW DRUGS. 2023; Vol. 41, Issue 1, pp. 86-92. DOI: 10.1007/s10637-022-01324-5
• Efficacy of salvage therapies after failure of adjuvant anti-PD-1 monotherapy for melanoma in the Chinese population: a multi-institutional cohort study Author: Jia, Dong-Dong; Xu, Yu; Li, Ting; Yang, Ji-Long; Chen, Yong; Li, Tao Journal: INVESTIGATIONAL NEW DRUGS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10637-023-01348-5
• Dasatinib in combination with BMS-754807 induce synergistic cytotoxicity in lung cancer cells through inhibiting lung cancer cell growth, and inducing autophagy as well as cell cycle arrest at the G1 phase Author: Zhang, Chan; Zhao, Xinan; Wang, Zifeng; Gong, Tao; Zhao, Hong; Zhang, Dong; Niu, Yuhu; Li, Xiaoning; Zhao, Xuhua; Li, Gaopeng; Dong, Xiushan; Zhang, Li; Liu, Chang; Xu, Jun; Yu, Baofeng Journal: INVESTIGATIONAL NEW DRUGS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10637-023-01360-9
• Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma Author: Hu, Shiqi; Liu, Yaqin; Yang, Qidong; Chen, Lin; Chai, Huizi; Xiao, Mingzhe; Qi, Chuang; Qiu, Wei Journal: INVESTIGATIONAL NEW DRUGS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10637-023-01363-6
• Viscosalactone B, a natural LSD1 inhibitor, inhibits proliferation in vitro and in vivo against prostate cancer cells Author: Yan, Gaobo; Zhang, Hongyan; Li, Yan; Miao, Guoqiang; Liu, Xiaolei; Lv, Qifan Journal: INVESTIGATIONAL NEW DRUGS. 2023; Vol. 41, Issue 1, pp. 134-141. DOI: 10.1007/s10637-023-01330-1